MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Thursday, June 8, 2017

1:15pm-2:45pm
Exploring the neurophysiology of cervical dystonia using TMS-EEG

S. Singh, H. Cho, N. Thirugnanasambandam, H. Shitara, O. Panyakaew, M. Hallett (Bethesda, MD, USA)

Dystonia  ·  Exhibit Hall C
1:15pm-2:45pm
Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?

T. Drori, J. Chapman, M. Lidar, P. Langevitz, Y. Shoenfeld, O. Cohen (Ramat-Gan, Israel)

Other  ·  Exhibit Hall C
1:15pm-2:45pm
F-18-DOPA-PET predicts impulsive behavior under dopaminergic therapy in Parkinson patients

J. Hammes, M. Tittgemeyer, C. Eggers, A. Drzezga, T. van Eimeren (Cologne, Germany)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
Factors associated with perceived walking difficulties in people with Parkinson’s disease

M. Kader, S. Ullén, S. Iwarsson, P. Odin, M. Nilsson (Lund, Sweden)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
Falls characteristics of male and female patients with Parkinson’s disease (PD)

G. Alg, A. Chatterjee, F. Zahir (Reading, United Kingdom)

Other  ·  Exhibit Hall C
1:15pm-2:45pm
Falls in Parkinson’s disease are related to delayed recovery time after unexpected external perturbations

V. Beretta, F. Barbieri, D. Orcioli-Silva, P. Santos, M. Pereira, R. Vitório, L. Gobbi (Rio Claro, Brazil)

Other  ·  Exhibit Hall C
1:15pm-2:45pm
Feasibility of using a smartphone application for the objective evaluation of Parkinson disease

R. Schneider, J. Adams, M. Elson, C. Tarolli, S. Sharma, A. Glidden, T. Felong, A. Zhan, R. Korn, S. Goldenthal, D. Harris, M. Xiong, M. Little, K. Biglan, R. Dorsey (Rochester, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
Five year longitudinal change in the MDS-UPDRS scores in early Parkinson’s disease participants: Results from the PPMI Study

T. Simuni, C. Caspell-Garcia, N. Seedorff, C. Coffey, S. Lasch, B. Mollenhauer, C. Tanner, K. Kieburtz, K. Marek (Chicago, IL, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
Focal dystonia as an early symptom of CACNA1A mutation: case report and literature review.

Y. Gu, K. Kumar, C. Sue (Sydney, Australia)

Dystonia  ·  Exhibit Hall C
1:15pm-2:45pm
Focused ultrasoud ventro-oral thalamotomy for musician’s dystonia

S. Horisawa, T. Yamaguchi, K. Abe, T. Taira (shinjyuku, Japan)

Dystonia  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 41
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley